Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|November 22, 2002
A controlled trial of a human papillomavirus type 16 vaccineLaura A Koutsky, Kevin A Ault, Cosette M Wheeler, et al.
The Journal of Infectious Diseases|December 21, 2004
A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent womenDarron R Brown, Marcia L Shew, Brahim Qadadri, et al.
Human Vaccines|July 6, 2007
Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirionsJudith F Smith, Michelle Brownlow, Martha Brown, et al.
Sexually Transmitted Infections|September 14, 2013
DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent womenAaron C Ermel, Marcia L Shew, Bree A Weaver, et al.
The Journal of Infectious Diseases|August 6, 2013
Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearanceMarcia L Shew, Aaron C Ermel, Bree A Weaver, et al.
Vaccine|March 4, 2021
Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccinesMargaret Stanley, Elmar Joura, Glorian P Yen, et al.
BMC Infectious Diseases|June 6, 2023
Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal studyYan Tong, Philip Tonui, Omenge Orang'o, et al.
International Journal of STD & AIDS|April 30, 2025
Lack of HIV suppression is associated with plasma aflatoxin B1 in Kenyan women living with HIV and receiving anti-retroviral therapyPhiliph Tonui, Yan Tong, Omenge Orang'o, et al.
Tumour Virus Research|May 7, 2022
Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young womenDarron R Brown, Xavier Castellsagué, Daron Ferris, et al.
Cancer Epidemiology|January 27, 2012
Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infectionsDorothy J Wiley, Emmanuel V Masongsong, Shuang Lu, et al.
Pageof 7